Breast cancer drug dampens immune response, protecting light-sensing cells of the eye
The breast cancer drug tamoxifen appears to protect light-sensitive cells in the eye from degeneration, according to a new study in mice. The drug prevented immune cells from removing injured photoreceptors, the light-sensitive cells of the retina in the back of the eye. The study, recently reported in theJournal of Neuroscience, suggests tamoxifen might work for the treatment of age-related macular degeneration (AMD) and retinitis pigmentosa (RP), blinding diseases that lack good treatment options.
Source: News from NEI - Category: Opthalmology Authors: balintfyj Source Type: news
More News: Age-Related Macular Degeneration (AMD) | Brain | Breast Cancer | Cancer | Cancer & Oncology | Neurology | Opthalmology | Retinitis Pigmentosa | Study | Tamoxifen